Yahoo Web Search

Sign In

Search results

  1. 760.00
    Add to watchlist
    -11.55 (-1.50%)
    At close:4:00 PM EDTFri. May 10, 2024
    760.50 +0.50 (+0.07%)
    After hrs:5:58 PM EDTFri. May 10, 2024
    Nasdaq Real Time Price (USD) · Market closed
    Full chart
    • Open
      774.02
      High
      777.42
      Low
      760.00
    • Mkt Cap
      722.31B
      P/E (TTM)
      111.93
      Div & Yield
      5.20 & 0.67%
    • Prev. Close
      771.55
      52 Wk. Low
      419.80
      52 Wk. High
      800.78

    More about LLY

    What analysts are saying
    Morningstar Bearish Published April 30 · Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer;... Read more
    Top stories

    Related stocks

    More on Yahoo Finance

  2. www.morningstar.com › stocks › XNYSLLY Stock Price Quote | Morningstar

    4 days ago · See the latest Eli Lilly and Co stock price (LLY:XNYS), related news, ... We raise our Eli Lilly fair value estimate to $540 from $500 following stronger-than-expected first-quarter results. In ...

    • 0.94
    • 0.52
    • 14.13

  3. www.cnbc.com › 2024/04/30 › eli-lilly-lly-earnings-qEli Lilly (LLY) earnings Q1 2024 - CNBC

    Apr 30, 2024 · Eli Lilly posted net income of $2.24 billion, or $2.48 a share, for the first quarter. That compares with a profit of $1.34 billion, or $1.49 a share, a year earlier. Excluding one-time items ...

  4. seekingalpha.com › symbol › LLYLLY Eli Lilly and Company - Seeking Alpha

    A high-level overview of Eli Lilly and Company (LLY) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

  5. investor.lilly.com › news-releases › news-releaseLilly Reports First-Quarter 2024 Financial Results and Raises ...

    Apr 30, 2024 · INDIANAPOLIS, April 30, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced its financial results for the first quarter of 2024. "Lilly's first quarter performance reflects solid year-over-year revenue growth with strong sales of Mounjaro and Zepbound," said David A. Ricks, Lilly's chair and CEO. "Our progress in addressing ...

  6. en.wikipedia.org › wiki › Eli_Lilly_and_CompanyEli Lilly and Company - Wikipedia

    3 days ago · Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union Army veteran of the American Civil War for whom the company was later named.

    • c. 39,000 (2022)
    • US$28.54 billion (2022)

  7. stockanalysis.com › stocks › llyEli Lilly and Company (LLY) - Stock Analysis

    2 days ago · About LLY. Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 ...

    • 722.07-750.01
    • 745.95
    • 749.16
    • 3,025,708

  8. finance.yahoo.com › news › eli-lilly-co-llyEli Lilly and Co (LLY) Surpasses Q1 Earnings Estimates and ...

    Apr 30, 2024 · LLY. Revenue: Reached $8.77 billion in Q1 2024, marking a 26% increase year-over-year, surpassing the estimated $8.92 billion. Net Income: Reported at $2.24 billion in Q1 2024, up 67% from the ...

  1. Searches related to LLY

    lly injectorslly dividend history
    lly egr deletelly yahoo
    lly duramax injectorslly news
    lly stock price todaylly stock
  2. People also search for